: Embryo implantation failure and spontaneous abortions represent the main causes of infertility in developed countries. Unfortunately, incomplete knowledge of the multiple factors involved in implantation and fetal development keeps the success rate of medically assisted procreation techniques relatively low. According to recent literature, cellular and molecular mechanisms of 'immunogenic tolerance' towards the embryo are crucial to establish an 'anti-inflammatory' state permissive of a healthy pregnancy. In this review we dissect the role played by the immune system in the endometrial-embryo crosstalk, with a particular emphasis towards the fork-head-box-p3 (Foxp3+) CD4+CD25+ regulatory T (Treg) cells and discuss the most recent therapeutic advances in the context of early immune-mediated pregnancy loss.
Immunobiology of pregnancy: from basic science to translational medicine / Colamatteo, Alessandra; Fusco, Clorinda; Micillo, Teresa; D'Hooghe, Thomas; de Candia, Paola; Alviggi, Carlo; Longobardi, Salvatore; Matarese, Giuseppe. - In: TRENDS IN MOLECULAR MEDICINE. - ISSN 1471-499X. - (2023). [10.1016/j.molmed.2023.05.009]
Immunobiology of pregnancy: from basic science to translational medicine
Colamatteo, Alessandra;Fusco, Clorinda;de Candia, Paola;Alviggi, Carlo;Matarese, Giuseppe
2023
Abstract
: Embryo implantation failure and spontaneous abortions represent the main causes of infertility in developed countries. Unfortunately, incomplete knowledge of the multiple factors involved in implantation and fetal development keeps the success rate of medically assisted procreation techniques relatively low. According to recent literature, cellular and molecular mechanisms of 'immunogenic tolerance' towards the embryo are crucial to establish an 'anti-inflammatory' state permissive of a healthy pregnancy. In this review we dissect the role played by the immune system in the endometrial-embryo crosstalk, with a particular emphasis towards the fork-head-box-p3 (Foxp3+) CD4+CD25+ regulatory T (Treg) cells and discuss the most recent therapeutic advances in the context of early immune-mediated pregnancy loss.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1471491423000990-main.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
1.23 MB
Formato
Adobe PDF
|
1.23 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.